Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares moved up 3.98% in last trading session and ended the day at $109.07. ALNY has a return on assets of -14.40%. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) quarterly performance is -16.87%.
Amgen’s newest cholesterol-lowering drug has only been approved for three days, with plans to launch this coming week. But already, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) in Cambridge is coming out with early-stage trial data suggesting it has a drug that can achieve similar results with far less frequent injections. Cambridge-based Alnylam (Nasdaq: ALNY) presented results of an early-stage trial today at a conference in London for a drug that lowers levels of a protein made in the liver called PCSK9, which in turn lowers lipids in the blood. That’s the same protein targeted by the newest drugs to control cholesterol ¬¬— including Praluent, by Sanofi and Regeneron, as well as Repatha by California-based Amgen (Nasdaq: AMGN), which was just approved last week.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the research and development of therapeutics based on its ribonucleic acid interference (RNAi). The Company’s pipeline focuses in three strategic therapeutic areas (STArs): Genetic Medicines, with a pipeline of RNAi therapeutics for the treatment of rare diseases; Cardio-Metabolic Disease, with a pipeline of RNAi therapeutics toward genetically validated, liver-expressed disease in cardiovascular and metabolic diseases, and hepatic infectious disease, with a pipeline of RNAi therapeutics for treatment of hepatic infectious diseases.
Elbit Systems Ltd. (NASDAQ:ESLT), announced that its wholly-owned subsidiary, CYBERBIT Ltd. (“CYBERBIT”), was recently awarded two contracts. One of the contracts was awarded by the National Police of a European country, and the second contract was awarded by a law enforcement agency of an African country. Each of the contracts, which are in a total amount that is not material to Elbit Systems, will be performed over a two-year period.
Elbit Systems Ltd is an Israel-based company engaged in the fields of defense, homeland security and commercial aviation. The Company develops and supplies airborne, land and naval systems and products for defense, homeland security and commercial aviation applications.
Elbit Systems Ltd. (NASDAQ:ESLT) ended the last trading day at $76.63. Company weekly volatility is calculated as 3.17% and price to cash ratio as 15.38. Elbit Systems Ltd. (NASDAQ:ESLT) showed a weekly performance of -3.92%.
St. Jude Medical, Inc. (NYSE:STJ), announced that five year results from the landmark FAME trial (Fractional Flow Reserve vs. Angiography in Multivessel Evaluation) have confirmed the long term benefits of fractional flow reserve (FFR) in guiding percutaneous coronary intervention (PCI) over angiography alone. An analysis of the study’s five year follow up data confirms that in patients with multi-vessel coronary artery disease, FFR-guided PCI can contribute to reductions in all-cause mortality, cardiac mortality and an overall use of health care resources.
St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.
On 28 August, St. Jude Medical Inc. (NYSE:STJ) shares moved up 0.26% and was closed at $72.62. STJ EPS growth in last 5 year was 8.90%. St. Jude Medical Inc. (NYSE:STJ) year to date (YTD) performance is 12.61%.
Maxwell Technologies (NASDAQ:MXWL) was downgraded by Zacks from a “hold” rating to a “sell” rating in a research report issued on Thursday, Market Beat.com reports.
Maxwell Technologies, Inc. develops, manufactures and markets energy storage and power delivery products and microelectronic products. The Company offers three product lines: ultracapacitors, high-voltage capacitors and radiation-hardened microelectronic products.
Maxwell Technologies, Inc. (NASDAQ:MXWL) shares moved up 4.87% in last trading session and ended the day at $5.38. MXWL Gross Margin is 33.80% and its has a return on assets of -13.40%. Maxwell Technologies, Inc. (NASDAQ:MXWL) quarterly performance is 8.25%.
Corning Inc. (NYSE:GLW) announced that Obi Worldphone(TM), designing in collaboration with Ammunition(TM), has selected Corning(R) Gorilla(R) Glass 4 for its newest flagship smartphone, the Obi Worldphone(TM) SF1. The Obi Worldphone(TM) SF1 is the company’s premier 4G/LTE smartphone, featuring a unique and eye-catching raised 5-inch display made of Corning Gorilla Glass 4, which is up to two times tougher than any competitive cover glass.
Corning Incorporated (Corning) is engaged in the manufacture of specialty glass and ceramics. The Company creates and makes keystone components that enable systems for consumer electronics, mobile emissions control, optical communications and life sciences.
Corning Inc. (NYSE:GLW) caters to the Technology space. It has a net profit margin of 29.40% and weekly performance is 3.07%. On the last day of trading company shares ended up $17.18. Corning Inc. (NYSE:GLW) distance from 50-day simple moving average (SMA50) is -7.86%.